Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States

التفاصيل البيبلوغرافية
العنوان: Readmission in patients undergoing percutaneous patent foramen ovale closure in the United States
المؤلفون: Chayakrit, Krittanawong, Bing, Yue, Muzamil, Khawaja, Anirudh, Kumar, Hafeez Ul Hassan, Virk, Zhen, Wang, Sana, Hanif, Umair, Khalid, Ali E, Denktas, Clifford J, Kavinsky, John J, Volpi, Hani, Jneid
المصدر: International Journal of Cardiology. 370:143-148
بيانات النشر: Elsevier BV, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Stroke, Cardiac Catheterization, Treatment Outcome, Atrial Flutter, Risk Factors, Septal Occluder Device, Recurrence, Atrial Fibrillation, Humans, Foramen Ovale, Patent, Cardiology and Cardiovascular Medicine, United States
الوصف: Current estimates suggest that a patent foramen ovale (PFO) may exist in up to 25% of the general population and is a potential risk factor for embolic, ischemic stroke. PFO closure complications include bleeding, need for procedure-related surgical intervention, pulmonary emboli, device malpositioning, new onset atrial arrhythmias, and transient atrioventricular block. Rates of PFO closure complications at a national level in the Unites States remain unknown. To address this, we performed a contemporary nationwide study using the 2016 and 2017 Nationwide Readmissions Database (NRD) to identify patterns of readmissions after percutaneous PFO closure. In conclusion, our study showed that following PFO closure, the most common complications were atrial fibrillation/atrial flutter followed by acute heart failure syndrome, supraventricular tachycardia and acute myocardial infarction.
تدمد: 0167-5273
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e697f874bdb48c5579c306a16afb14a
https://doi.org/10.1016/j.ijcard.2022.10.135
حقوق: CLOSED
رقم الأكسشن: edsair.doi.dedup.....0e697f874bdb48c5579c306a16afb14a
قاعدة البيانات: OpenAIRE